Sector
PharmaceuticalsOpen
₹17.46Prev. Close
₹17.03Turnover(Lac.)
₹0.56Day's High
₹17.46Day's Low
₹16.2152 Week's High
₹27.8252 Week's Low
₹15.46Book Value
₹11.19Face Value
₹10Mkt Cap (₹ Cr.)
4.86P/E
0EPS
0Divi. Yield
029 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
16 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2.06 | 3.31 | 4.22 | 5.79 |
Net Worth | 5.06 | 6.31 | 7.22 | 8.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 34.97 | 49.61 | 55.78 | 60.54 |
yoy growth (%) | -29.5 | -11.05 | -7.86 | 29.14 |
Raw materials | -30.02 | -42.1 | -48.84 | -52.19 |
As % of sales | 85.84 | 84.85 | 87.56 | 86.19 |
Employee costs | -2.36 | -3.08 | -2.98 | -1.98 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.35 | 0.81 | 1.96 | 1.75 |
Depreciation | -0.03 | -0.03 | -0.03 | -0.03 |
Tax paid | -0.19 | -0.22 | -0.67 | -0.36 |
Working capital | -0.47 | 1.27 | 0.39 | 3.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -29.5 | -11.05 | -7.86 | 29.14 |
Op profit growth | -181.67 | -62.6 | 59.04 | -13.56 |
EBIT growth | -137.15 | -56.93 | 10.78 | 30.06 |
Net profit growth | -193.12 | -53.86 | -7.99 | 46.66 |
| Particulars (Rupees in Crores.) | Mar-2023 |
|---|---|
Gross Sales | 0.48 |
Excise Duty | 0 |
Net Sales | 0.48 |
Other Operating Income | 0 |
Other Income | 0.24 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Director
Brij Raj Gupta
Company Sec. & Compli. Officer
Priyanka Sharma
Independent Director
Pooja Jha
Independent Director
Mayank Jain
C-64 Lajpat Nagar-1 1st Floor,
New Delhi - 110024
Tel: -
Website: http://www.brawnbiotech.com
Email: solution@brawnbiotech.com
1515 1st Floor,
Bhisham Pitamah Marg, Kotla Mubarakpur,
New Delhi-110003
Tel: 91-011-24649720/2469
Website: www.rcmcdelhi.com
Email: rcmc@theoffice.net
Summary
Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985. Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Braw...
Read More
Reports by Brawn Biotech Ltd
What is the Brawn Biotech Ltd share price today?
What is the Market Cap of Brawn Biotech Ltd?
What is the PE and PB ratio of Brawn Biotech Ltd?
What is the 52 Week High and Low of Brawn Biotech Ltd?
What is the CAGR of Brawn Biotech Ltd?
What is the shareholding pattern of Brawn Biotech Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.